CD274 and neoplasm: The tumour evasion mechanism mediated by PD-L1 upregulation in response to DDR-targeted agents can be reverted by combining these agents with the aforementioned antibodies that block the interactions of PD-L1 with PD1 [22,56,60,74] or with agents that alter PD-L1 expression [78].